n-acetylsphingosine has been researched along with anisomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, A; Hirano, K; Hosoi, Y; Kang, Y; Koyama, H; Matsumoto, Y; Morita, A; Sakai, K; Suzuki, N; Zhu, J | 1 |
| Broussard, SR; Dantzer, R; Freund, GG; Johnson, RW; Kelley, KW; LeCleir, JM; McCusker, RH; Shen, WH; Strle, K | 1 |
2 other study(ies) available for n-acetylsphingosine and anisomycin
| Article | Year |
|---|---|
Decreased c-Myc expression and its involvement in X-ray-induced apoptotic cell death of human T-cell leukaemia cell line MOLT-4.
Topics: Anisomycin; Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Leukemia, T-Cell; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-myc; RNA, Messenger; Sphingosine; Tumor Suppressor Protein p53; X-Rays | 2003 |
C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
Topics: Animals; Anisomycin; Cell Differentiation; Cell Line; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Humans; Inflammation; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; JNK Mitogen-Activated Protein Kinases; Kinetics; Mice; Myoblasts; Myogenin; Phosphoproteins; Phosphorylation; Receptor, IGF Type 1; Recombinant Proteins; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Tumor Necrosis Factor-alpha; Tyrosine | 2006 |